Vertex Pharmaceuticals Incorporated
DE ˙ XTRA ˙ US92532F1003
368,15 € ↑3,40 (0,93%)
2026-06-04
DEL PRIS
SecurityDE:VX1 / Vertex Pharmaceuticals Incorporated
InstitutionSowell Financial Services LLC
Latest Disclosed Ownership2,775 shares
Latest Disclosed Value $ 1,239,363
Sowell Financial Services LLC reports 1.39% decrease in ownership of VX1 / Vertex Pharmaceuticals Incorporated

On April 20, 2026 - Sowell Financial Services LLC filed a 13F-HR form disclosing ownership of 2,775 shares of Vertex Pharmaceuticals Incorporated (DE:VX1) valued at $1,068,652 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 2,814 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -1.39% during the quarter. The current value of the position is $1,021,616 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,775 -39 -1.39 1,239 -2.82 0.0458
2026-01-21 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,814 -1,198 -29.86 1,276 -18.84 0.0469
2025-10-17 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,012 1,215 43.44 1,571 26.18 0.0603
2025-07-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,797 -29 -1.03 1,245 -9.12 0.0507
2025-04-17 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,826 2,826 1,370 0.0624
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS STOCK 92532F100 0 -3,188 -100.00 0 -100.00
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS STOCK 92532F100 3,188 3,188 1 0.0775
2021-08-05 2021-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 0 -2,529 -100.00 0 -100.00
2021-05-07 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 2,529 83 3.39 539 -6.75 0.0188
2021-01-13 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,446 283 13.08 578 -1.87 0.0247
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,163 8 0.37 589 -5.91 0.0294
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 2,155 368 20.59 626 47.29 0.0344
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,787 -870 -32.74 425 -26.98 0.0315
2020-02-07 2019-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 2,657 489 22.56 582 58.58 0.0443
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,168 410 23.32 367 13.62 0.0303
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,758 0 0.00 323 11.00 0.0361
2019-03-05 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,758 401 29.55 291 11.07 0.0412
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,357 50 3.83 262 14.41 0.0380
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,307 1,307 229 0.0486
2017-11-07 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -2,762 -100.00 0 -100.00
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,762 0 0.00 423 30.15 0.1201
2017-05-31 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,762 23 0.84 325 32.65 0.0960
2017-02-27 2016-12-31 13F Vertex Pharmaceuticals Inc Com COM 92532F100 2,739 2,739 245 0.0820
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.